


There is no fund objective available from this fund manager.
| Name | % Net Assets | 
|---|---|
| GlaxoSmithKline PLC | 6.4% | 
| Royal Dutch Shell PLC | 6.1% | 
| AstraZeneca PLC | 5.9% | 
| British American Tobacco PLC | 5.4% | 
| BT Group PLC | 5.3% | 
| Unilever PLC | 3.9% | 
| Imperial Tobacco Group PLC | 3.3% | 
| Legal & General Group PLC | 3.1% | 
| Compass Group PLC | 3.0% | 
| BG Group PLC | 2.5% | 
| Key | % Net Assets | 
|---|---|
| 6.4% | |
| 6.1% | |
| 5.9% | |
| 5.4% | |
| 76.2% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 209.14p | 
| Currency | GBP | 
| Change | 0.56p | 
| % | 0.27% | 
| YTD change | 15.91p | 
| YTD % | 8.23% | 
| Fund Inception | 30/09/1985 | 
|---|---|
| Fund Manager | n/a | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research